Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▾
GTBP	GT Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.35M	n/a	-490.0%	n/a	-$6.68
IMNN	Imunon, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$14.50M	n/a	-205.3%	n/a	-$6.83
BHVN	Biohaven Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$738.82M	n/a	n/m	n/a	-$6.86
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
DWTX	Dogwood Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.26M	n/a	-45.7%	n/a	-$7.13
SRPT	Sarepta Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.20B	-$713.41M	-32.5%	-62.5%	15.6%	-$7.13
SHPH	Shuttle Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.72M	n/a	-519.9%	n/a	-$7.16
MTVA	MetaVia Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.97M	n/a	-243.3%	n/a	-$7.35
PRFX	PRF Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$17.0K	-$5.02M	n/m	-58.8%	n/a	-$7.47
DRMA	Dermata Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.56M	n/a	-121.5%	n/a	-$8.16
CLRB	Cellectar Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$21.79M	n/a	-255.2%	n/a	-$8.35
ZBIO	Zenas BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$377.74M	n/m	-156.0%	100.0%	-$8.44
NXTS	Nexentis Technologies Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$4.00M	n/a	-25.0%	n/a	-$8.61
SXTC	China SXT Pharmaceuticals, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.14M	-$6.21M	-545.2%	-20.9%	-34.6%	-$9.13
HYPD	Hyperion Defi, Inc. Manufacturing · Year ended 2025-12-31 · USD	$813.5K	-$45.31M	n/m	-110.4%	n/m	-$9.40
NKTR	Nektar Therapeutics Manufacturing · Year ended 2025-12-31 · USD	$55.23M	-$164.08M	-297.1%	-182.6%	-43.9%	-$9.73
PRGO	Perrigo Co PLC Manufacturing · Year ended 2025-12-31 · USD	$4.25B	-$1.43B	-33.5%	-48.6%	-2.8%	-$10.29
PCSA	Processa Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$13.56M	n/a	-243.2%	n/a	-$10.36
HCWB	HCW Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.2K	-$7.96M	n/m	-287.9%	-97.9%	-$10.63
EVMN	Evommune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.00M	-$68.87M	-529.8%	-33.5%	85.7%	-$11.22
SXTP	60 Degrees Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.01M	-$7.37M	-732.5%	-212.7%	65.5%	-$11.73
ADIL	Adial Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.98M	n/a	-151.2%	n/a	-$11.93
KRRO	Korro Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.39M	-$117.26M	n/m	-228.0%	181.5%	-$12.48
ARTL	Artelo Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.88M	n/a	n/a	n/a	-$12.52
MDGL	Madrigal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$958.40M	-$288.28M	-30.1%	-47.8%	432.1%	-$12.85

Rows per page: 2550 100